Research Article
GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
Table 3
Univariate and multivariate Cox regression analysis of the GABPA expression and disease-free survival in EC patients.
| | Variable | Univariable | Multivariable | | HR (95% CI) | value | HR (95% CI) | value |
| | Age (<60 vs ≥60) | 1.680 (1.017-2.777) | 0.043 | 1.670 (1.011-2.760) | 0.045 | | Histology (type I vs type II) | 1.629 (1.024-2.593) | 0.039 | — | 0.416 | | Grade (G1-2 vs G3) | 1.499 (0.952-2.630) | 0.081 | — | 0.332 | | Stage (stage I vs stage II-IV)) | 2.281 (1.482-3.511) | ≤0.001 | 2.219 (1.441-3.418) | ≤0.001 | | Surgical (open vs mini-invasive) | 1.039 (0.657-1.643) | 0.870 | | | | GABPA (low vs high) | 0.584 (0.375-0.910) | 0.018 | 0.619 (0.397-0.966) | 0.045 |
|
|
GABPA: GA-binding protein A; EC: endometrial carcinoma; age: age of endometria carcinoma diagnosis; HR: hazard ratio; CI: confidence interval; bold type and ( ) indicate statistical significance. |